Comparação De Diferentes Protocolos Na Estratificação Do Risco Cardiovascular E Indicação Do Uso De Estatina Em Pacientes Portadores De Hipertensão Arterial

Abstract

Objective: To Evaluate The Difference In Indication Of The Use Of Statin In Patients Submitted To Different Protocols Of Stratification Of Cardiovascular Risk For The Treatment Of Dyslipidemia. Methods: A Total Of 641 Patient Charts Were Reviewed Regularly In The Osvaldo Ramos Foundation Hypertension Outpatient Clinic, Who Were Without The Use Of Statin. These Patients Were Submitted To The Application Of Different Guidelines To Classify The Cardiovascular Risk. The Framingham And Pooled Cohort Equation Scores Were Used. After These Patients Were Submitted To Different Protocols For Calculating Cardiovascular Risk, The Criteria Were Applied According To Each National Cholesterol Education Program's Adult Treatment Panel Iii And American College Of Cardiology/American Heart Association 2013 Protocol For The Start Of The Use Of Statins. Results: Of The 641 Patients Analyzed (56.9 ± 9.7 Years, 66.1% Female, 30.7% Diabetic, 31% Black, 11.2% Smoker, 44.1% With Metabolic Syndrome, 10 (33%) Were Identified As Having

Objetivo: Avaliar A Diferença Na Indicação Do Uso De Estatina Em Pacientes Submetidos À Aplicação De Diferentes Protocolos De Estratificação De Risco Cardiovascular Para O Tratamento Da Dislipidemia. Métodos: Foram Revisados 641 Prontuários De Pacientes Regularmente Atendidos No Ambulatório De Hipertensão Da Fundação Osvaldo Ramos, Os Quais Estavam Sem O Uso De Estatina. Tais Pacientes Foram Submetidos À Aplicação De Diferentes Ferramentas Para Classificar O Risco Cardiovascular. Os Escores Utilizados Foram O De Framingham E A Pooled Cohort Equation. Após Tais Pacientes Serem Submetidos A Diferentes Protocolos Para O Cálculo Do Risco Cardiovascular, Foram Aplicados Os Critérios Conforme Cada Protocolo National Cholesterol Education Program"S Adult Treatment Panel Iii E American College Of Cardiology/American Heart Association 2013 Para O Início Do Uso De Estatinas. Resultados: Dos 641 Pacientes Analisados (56,9 ± 9,7 Anos; 66,1% Sexo Feminino; 30,7% Diabéticos; 31% Negros; 11,2% Tabagista; 44,1% Com Presença